Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer

References

• Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J. Clin.57(1), 43–66 (2007).
   PubMed Web of Science ®Google Scholar
• Cheng L, Jones TD, McCarthy RP et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am. J. Pathol.166(5), 1533–1539 (2005).
   PubMed Web of Science ®Google Scholar
• Fadl-Elmula I, Gorunova L, Lundgren R et al. Chromosomal abnormalities in two bladder carcinomas with secondary squamous cell differentiation. Cancer Genet. Cytogenet.102(2), 125–130 (1998).
   PubMed Web of Science ®Google Scholar
• Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette–Guérin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J. Urol.168(5), 1964–1970 (2002).
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol.19(3), 666–675 (2001).
   PubMed Web of Science ®Google Scholar
• Kassouf W, Swanson D, Kamat AM et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. J. Urol.175(6), 2058–2062 (2006).
   PubMed Web of Science ®Google Scholar
• Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med.349(9), 859–866 (2003).
   PubMed Web of Science ®Google Scholar
• Siefker-Radtke A. Systemic chemotherapy options for metastatic bladder cancer. Expert Rev. Anticancer Ther.6(6), 877–885 (2006).
   PubMed Web of Science ®Google Scholar
• Sternberg CN, de Mulder P, Schornagel JH et al. Seven year update of an EORTC Phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours. Eur. J. Cancer42(1), 50–54 (2006).
   PubMed Web of Science ®Google Scholar
• Roberts JT, von der Maase H, Sengelov L et al. Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/ cisplatin in patients with locally advanced and metastatic bladder cancer. Ann. Oncol.17(Suppl. 5) V118–V122 (2006).
   PubMedGoogle Scholar
• Lopez-Beltran A, Requena MJ, Alvarez-Kindelan J et al. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J. Clin. Pathol.60(3), 332–335 (2007).
   PubMed Web of Science ®Google Scholar
• Martin JE, Jenkins BJ, Zuk RJ et al. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J. Clin. Pathol.42(3), 250–253 (1989).
   PubMed Web of Science ®Google Scholar
• Logothetis CJ, Johnson DE, Chong C et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. J. Clin. Oncol.6(10), 1590–1596 (1988).
   PubMed Web of Science ®Google Scholar
• Honma I, Masumori N, Sato E et al. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urology64(4), 744–748 (2004).
   PubMed Web of Science ®Google Scholar
• Black PC, Kassouf W, Brown GA et al. Variant histology in bladder cancer – experience in 1246 patients undergoing cystectomy. Presented at: The American Urological Association Anuual Meeting. Anaheim, CA, USA, 19–24 May 2007.
   Google Scholar
• Cheng L, Pan CX, Yang XJ et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer101(5), 957–962 (2004).
   PubMed Web of Science ®Google Scholar
• Siefker-Radtke AO, Dinney CP, Abrahams NA et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J. Urol.172(2), 481–484 (2004).
   PubMed Web of Science ®Google Scholar
• Mangar SA, Logue JP, Shanks JH et al. Small-cell carcinoma of the urinary bladder: 10-year experience. Clin. Oncol. (R. Coll. Radiol.)16(8), 523–527 (2004).
   PubMed Web of Science ®Google Scholar
• Bex A, Nieuwenhuijzen JA, Kerst M et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology65(2), 295–299 (2005).
   PubMed Web of Science ®Google Scholar
• Quek ML, Nichols PW, Yamzon J et al. Radical cystectomy for primary neuroendocrine tumors of the bladder: the University of Southern California experience. J. Urol.174(1), 93–96 (2005).
   PubMed Web of Science ®Google Scholar
• Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer103(6), 1172–1178 (2005).
   PubMed Web of Science ®Google Scholar
• Bastus R, Caballero JM, Gonzalez G et al. Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: results in five cases. Eur. Urol.35(4), 323–326 (1999).
   PubMed Web of Science ®Google Scholar
• Karpman E, Goldberg Z, Saffarian A et al. Analysis of treatment for small cell cancer of the bladder and report of three cases. Urology64(3), 494–498 (2004).
   PubMed Web of Science ®Google Scholar
• Lester JF, Hudson E, Barber JB. Bladder preservation in small cell carcinoma of the urinary bladder: an institutional experience and review of the literature. Clin. Oncol. (R. Coll. Radiol.)18(8), 608–611 (2006).
   PubMed Web of Science ®Google Scholar
• Lohrisch C, Murray N, Pickles T, Sullivan L. Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer86(11), 2346–2352 (1999).
   PubMed Web of Science ®Google Scholar
• Auperin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N. Engl. J. Med.341(7), 476–484 (1999).
   PubMed Web of Science ®Google Scholar
• Siefker-Radtke AO, Kamat AM, Grossman HB et al. Prospective evidence supporting the utility of neoadjuvant chemotherapy in small cell urothelial cancer: preliminary results from a Phase II clinical trial at the MD Anderson Cancer Center. Presented at: The American Urological Association Anuual Meeting. Atlanta, GA, USA, 20–25 May 2006.
   Google Scholar
• Noda K, Nishiwaki Y, Kawahara M et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N. Engl. J. Med.346(2), 85–91 (2002).
   PubMed Web of Science ®Google Scholar
• Board RE, Thatcher N, Lorigan P. Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism? Drugs66(15), 1919–1931 (2006).
   PubMed Web of Science ®Google Scholar
• Sung MT, Wang M, Maclennan G et al. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J. Pathol.211(4), 420–430 (2007).
   PubMed Web of Science ®Google Scholar
• Baschinsky DY, Chen JH, Vadmal MS et al. Carcinosarcoma of the urinary bladder – an aggressive tumor with diverse histogenesis. A clinicopathologic study of 4 cases and review of the literature. Arch. Pathol. Lab. Med.124(8), 1172–1178 (2000).
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Pacelli A, Rothenberg HJ et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J. Urol.159(5), 1497–1503 (1998).
   PubMed Web of Science ®Google Scholar
• Wick MR, Ritter JH, Humphrey PA. Sarcomatoid carcinomas of the lung: a clinicopathologic review. Am. J. Clin. Pathol.108(1), 40–53 (1997).
   PubMed Web of Science ®Google Scholar
• Wick MR, Swanson PE. Carcinosarcomas: current perspectives and an historical review of nosological concepts. Semin. Diagn. Pathol.10(2), 118–127 (1993).
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Cheng L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum. Pathol.37(11), 1371–1388 (2006).
   PubMed Web of Science ®Google Scholar
• Torenbeek R, Blomjous CE, de Bruin PC et al. Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am. J. Surg. Pathol.18(3), 241–249 (1994).
   PubMed Web of Science ®Google Scholar
• Wright JL, Black PC, Brown GA et al. Differences in survival between patients with sarcomatoid carcinoma, carcinosarcoma and transitional cell carcinoma of the bladder. J. Urol. (2007) (In Press).
   Google Scholar
• Amin MB, Ro JY, el-Sharkawy T et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am. J. Surg. Pathol.18(12), 1224–1232 (1994).
   PubMed Web of Science ®Google Scholar
• Johansson SL, Borghede G, Holmang S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J. Urol.161(6), 1798–1802 (1999).
   PubMed Web of Science ®Google Scholar
• Kamat AM, Gee JR, Dinney CP et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J. Urol.175(3 Pt 1), 881–885 (2006).
   PubMed Web of Science ®Google Scholar
• Samaratunga H, Khoo K. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology45(1), 55–64 (2004).
   PubMed Web of Science ®Google Scholar
• Ghoneim MA, el-Mekresh MM, el-Baz MA et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J. Urol.158(2), 393–399 (1997).
   PubMed Web of Science ®Google Scholar
• Khaled HM. Systemic management of bladder cancer in Egypt: revisited. J. Egypt Natl Cancer Inst.17(3), 127–131 (2005).
   PubMedGoogle Scholar
• Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. Br. J. Urol. Int.93(2), 216–220 (2004).
   Google Scholar
• Rundle JS, Hart AJ, McGeorge A et al. Squamous cell carcinoma of bladder. A review of 114 patients. Br. J. Urol.54(5), 522–526 (1982).
   PubMedGoogle Scholar
• El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int. J. Clin. Oncol.10(1), 20–25 (2005).
   PubMedGoogle Scholar
• El-Shazli S, Anwar H, Ramzy S, Al-Didi M. Extended lymphadenectomy to the lower paraaortic nodes during radical cystectomy. J. Egypt Natl Cancer Inst.16(1), 22–28 (2004).
   PubMedGoogle Scholar
• Zaghloul MS. Distant metastasis from bilharzial bladder cancer. Cancer77(4), 743–749 (1996).
   PubMed Web of Science ®Google Scholar
• Serretta V, Pomara G, Piazza F, Gange E. Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases. Eur. Urol.37(1), 85–89 (2000).
   PubMed Web of Science ®Google Scholar
• Khaled H, El Hattab O, Moneim DA et al. A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer. Urol. Oncol.23(4), 254–260 (2005).
   PubMed Web of Science ®Google Scholar
• Zaghloul MS, Awwad HK, Akoush HH et al. Postoperative radiotherapy of carcinoma in bilharzial bladder: improved disease free survival through improving local control. Int. J. Radiat. Oncol. Biol. Phys.23(3), 511–517 (1992).
   PubMed Web of Science ®Google Scholar
• Herr HW, Faulkner JR, Grossman HB et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J. Clin. Oncol.22(14), 2781–2789 (2004).
   PubMed Web of Science ®Google Scholar
• Ghoneim MA, Ashamallah AK, Awaad HK, Whitmore WF Jr. Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J. Urol.134(2), 266–268 (1985).
   PubMed Web of Science ®Google Scholar
• Swanson DA, Liles A, Zagars GK. Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J. Urol.143(1), 37–40 (1990).
   PubMed Web of Science ®Google Scholar
• Calvo FA, Meirino RM, Orecchia R. Intraoperative radiation therapy first part: rationale and techniques. Crit. Rev. Oncol. Hematol.59(2), 106–115 (2006).
   PubMed Web of Science ®Google Scholar
• Argiris A. Induction chemotherapy for head and neck cancer: will history repeat itself? J. Natl Compr. Cancer Netw.3(3), 393–403 (2005).
   PubMedGoogle Scholar
• Gad-el-Mawla N, Hamza MR, Zikri ZK et al. Chemotherapy in invasive carcinoma of the bladder. A review of Phase II trials in Egypt. Acta Oncol.28(1), 73–76 (1989).
   Google Scholar
• Gad-el-Mawla N, Mansour MA, Eissa S et al. A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder. Ann. Oncol.2(2), 137–140 (1991).
   PubMed Web of Science ®Google Scholar
• Khaled HM, Gad el-Mawla N, el-Said A et al. Combination chemotherapy for advanced bilharzial bladder carcinoma. Ann. Oncol.7(7), 751–754 (1996).
   PubMed Web of Science ®Google Scholar
• Khaled HM, Hamza MR, Mansour O et al. A Phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma. Eur. J. Cancer36(Suppl. 2) 34–37 (2000).
   PubMed Web of Science ®Google Scholar
• Khaled HM, Zaghloul MS, Ghoneim M et al. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive bladder cancer: effect on bladder preservation and survival. Proc. Am. Soc. Clin. Oncol.22, 411 (2003) (Abstract 1652).
   Google Scholar
• Zaghloul MS, Khaled HM, Lotayef H, William H. Adjuvant chemoradiotherapy after radical cystectomy in advanced high risk bladder cancer: a prospective randomized trial. Proc. Am. Soc. Clin. Oncol.24(18S), 18S (2006) (Abstract 4545).
   Google Scholar
• Galsky MD, Iasonos A, Mironov S et al. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology69(2), 255–259 (2007).
   PubMed Web of Science ®Google Scholar
• Bonner JA, Harari PM, Giralt J et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med.354(6), 567–578 (2006).
   PubMed Web of Science ®Google Scholar
• Guo CC, Fine SW, Epstein JI. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am. J. Surg. Pathol.30(7), 883–891 (2006).
   PubMed Web of Science ®Google Scholar
• Black PC, Brown GA, Shrader M et al. Molecular correlates of response to EGFR-targeted therapy in bladder cancer. Presented at: The 2007 American Association for Cancer Research Annual Meeting. Los Angeles, CA, USA, 14–18 April 2007.
   Google Scholar
• Sheldon CA, Clayman RV, Gonzalez R et al. Malignant urachal lesions. J. Urol.131(1), 1–8 (1984).
   PubMed Web of Science ®Google Scholar
• Henly DR, Farrow GM, Zincke H. Urachal cancer: role of conservative surgery. Urology42(6), 635–639 (1993).
   PubMed Web of Science ®Google Scholar
• Wright JL, Porter MP, Li CI et al. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer107(4), 721–728 (2006).
   PubMed Web of Science ®Google Scholar
• Zaghloul MS, Nouh A, Nazmy M et al. Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol. Oncol.24(1), 13–20 (2006).
   PubMed Web of Science ®Google Scholar
• Ashley RA, Inman BA, Sebo TJ et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer107(4), 712–720 (2006).
   PubMed Web of Science ®Google Scholar
• el-Mekresh MM, el-Baz MA, Abol-Enein H, Ghoneim MA. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br. J. Urol.82(2), 206–212 (1998).
   PubMedGoogle Scholar
• Pinthus JH, Haddad R, Trachtenberg J et al. Population based survival data on urachal tumors. J. Urol.175(6), 2042–2047; discussion 2047 (2006).
   PubMed Web of Science ®Google Scholar
• Siefker-Radtke AO, Gee J, Shen Y et al. Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience. J. Urol.169(4), 1295–1298 (2003).
   PubMed Web of Science ®Google Scholar
• Madeb R, Knopf JK, Nicholson C et al. The use of robotically assisted surgery for treating urachal anomalies. Br. J. Urol. Int.98(4), 838–842 (2006).
   Google Scholar
• Wadhwa P, Kolla SB, Hemal AK. Laparoscopic en blocpartial cystectomy with bilateral pelvic lymphadenectomy for urachal adenocarcinoma. Urology67(4), 837–843 (2006).
   PubMed Web of Science ®Google Scholar
• Logothetis CJ, Samuels ML, Ogden S. Chemotherapy for adenocarcinomas of the bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C. Urology26(3), 252–255 (1985).
   PubMed Web of Science ®Google Scholar
• Siefker-Radtke A. Urachal carcinoma: surgical and chemotherapeutic options. Expert Rev. Anticancer Ther.6(12), 1715–1721 (2006).
   PubMed Web of Science ®Google Scholar
• Goebell PJ, Groshen S, Schmitz-Drager BJ et al. Concepts for banking tissue in urologic oncology – the International Bladder Cancer Bank. Clin. Cancer Res.11(2 Pt 1), 413–415 (2005).
   PubMed Web of Science ®Google Scholar
• Kantor AF, Hartge P, Hoover RN, Fraumeni JF Jr. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res.48(13), 3853–3855 (1988).
   PubMed Web of Science ®Google Scholar
• Lynch CF, Cohen MB. Urinary system. Cancer75(Suppl. 1), 316–329 (1995).
   PubMed Web of Science ®Google Scholar